BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1949739)

  • 1. [The immunological reactivity characteristics of patients with polycythemia vera].
    Guseva SA; Zverkova AS; Bal'shin MD; Grin'ko VI
    Vrach Delo; 1991 Aug; (8):63-6. PubMed ID: 1949739
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of alcohol and smoking on immunological reactivity].
    Shubik VM
    Gig Sanit; 1983 Oct; (10):59-63. PubMed ID: 6360802
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of the Soviet preparations, fotrin and imifos, in erythremia].
    Petrov KIa; Buglaev AP
    Probl Gematol Pereliv Krovi; 1980 Aug; 25(8):14-6. PubMed ID: 7413620
    [No Abstract]   [Full Text] [Related]  

  • 4. [Role of ascorbic acid in regulating immunological reactions].
    Pletsityĭ KD
    Vopr Pitan; 1979; (4):18-27. PubMed ID: 384669
    [No Abstract]   [Full Text] [Related]  

  • 5. [Depressive effect of hormones during pregnancy on cellular-type immunological reactions (a review of the literature)].
    Ivanova LA; Trunova LA
    Vopr Okhr Materin Det; 1978 May; 23(5):54-8. PubMed ID: 351951
    [No Abstract]   [Full Text] [Related]  

  • 6. [Various indices of humoral and cellular immunity in patients with polycythemia vera].
    Kotsiubinskiĭ NN; Dygin VP
    Gematol Transfuziol; 1986 Feb; 31(2):32-5. PubMed ID: 3956980
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effectiveness of cytostatic therapy of polycythemia vera].
    Kovaleva LG; Kho PI
    Gematol Transfuziol; 1986 Jul; 31(7):42-6. PubMed ID: 3744014
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immune deficiences during pyoderma gangrenosum associated with a polycythemia vera].
    Deschamps P; Leroy D; Dresch C; Michel M
    Nouv Presse Med; 1977 Jun; 6(26):2339-41. PubMed ID: 887420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The feature of T cell clonality with polycythemia vera].
    Li Y; Yang L; Chen S
    Zhonghua Xue Ye Xue Za Zhi; 1999 Nov; 20(11):570-2. PubMed ID: 11721372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The function of the T immunity system in patients with hemoblastoses undergoing polychemotherapy].
    Zverkova AS; Bratus' GG
    Vrach Delo; 1991 Feb; (2):39-43. PubMed ID: 2058119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Modification of the immune response by histamine in normal and immunodeficient patients (dysgammaglobulinemia with hyper IgM)].
    Hébert J; Beaudoin R; Aubin M
    Union Med Can; 1978 Apr; 107(4):371-5. PubMed ID: 306149
    [No Abstract]   [Full Text] [Related]  

  • 12. Tumor induced immunosuppression.
    Roth JA
    Surg Gynecol Obstet; 1983 Feb; 156(2):233-40. PubMed ID: 6186039
    [No Abstract]   [Full Text] [Related]  

  • 13. [The relationship of immunological reactivity to blood groups].
    Zemskov AM; Perederiĭ VG; Zaikin VV; Pritulina IuG; Salomakhin GG; Bobrova NV; Vysotskaia AT; Poliakova SD; Shvets NI
    Vrach Delo; 1990 Apr; (4):55-7. PubMed ID: 2275169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Methodological problems of screening immunotropic agents].
    Uteshev BS
    Farmakol Toksikol; 1984; 47(3):5-13. PubMed ID: 6610565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Stidoes pf the production of precipitating antibodies in conditions of therapeutic immunosuppression].
    Luca N
    Med Interna (Bucur); 1972 May; 24(5):577-82. PubMed ID: 4626131
    [No Abstract]   [Full Text] [Related]  

  • 16. From efficacy to safety: a Polycythemia Vera Study group report on hydroxyurea in patients with polycythemia vera.
    Fruchtman SM; Mack K; Kaplan ME; Peterson P; Berk PD; Wasserman LR
    Semin Hematol; 1997 Jan; 34(1):17-23. PubMed ID: 9025158
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prognostic significance of typical immune reactions in myocardial infarction].
    Zemskov AM; Alekhina OD; Zemskov VM; Zemskov MA; Zoloedov VI
    Ter Arkh; 2008; 80(1):32-7. PubMed ID: 18326224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of polycythemia vera in the polyclinic].
    Osechenskaia GV; Krasiukova LI
    Sov Med; 1979 Aug; (8):62-5. PubMed ID: 515829
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of erythremia with imifos (10-year experience with hospital and ambulatory treatment of patients)].
    Demidova AV; Shcherbak EM; Kozlova AF
    Ter Arkh; 1975; 47(1):56-62. PubMed ID: 1114449
    [No Abstract]   [Full Text] [Related]  

  • 20. [Various parameters of cellular immunity in persons exposed to petroleum derivatives].
    Zeman K; Tchórzewski H; Majewska E; Baj Z; Nowak Z; Kocur E; Pokoca L
    Pol Tyg Lek; 1988 May; 43(20):626-30. PubMed ID: 3265205
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.